| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/28/2006 | EP1673985A1 Functional sweetener |
| 06/28/2006 | EP1673631A2 Biomarkers for the prediction of drug-induced diarrhoea |
| 06/28/2006 | EP1673467A2 Systems and methods for assessing neuronal degeneration |
| 06/28/2006 | EP1673439A2 Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders |
| 06/28/2006 | EP1673384A2 Nitrosated glutamic acid compounds, compositions and methods of use |
| 06/28/2006 | EP1673376A2 Treating bone-related disorders with selective androgen receptor modulators |
| 06/28/2006 | EP1673374A2 Substituted tricyclic heterocycles and their uses |
| 06/28/2006 | EP1673373A2 Indole derivatives |
| 06/28/2006 | EP1673372A1 Non-amide nonanes |
| 06/28/2006 | EP1673369A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 06/28/2006 | EP1673368A1 Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes |
| 06/28/2006 | EP1673360A1 Furan derivatives as ep4 receptor antagonists |
| 06/28/2006 | EP1673359A1 Process for the preparation of crystalline forms of orlistat |
| 06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/28/2006 | EP1673356A1 Substituted benzylaminoalkylene heterocycles |
| 06/28/2006 | EP1673353A1 Transition state structure and inhibitors of thymidine phosphorylases |
| 06/28/2006 | EP1673349A1 Benzimidazole derivates: preparation and pharmaceutical applications |
| 06/28/2006 | EP1673348A2 Benzoimidazole compounds |
| 06/28/2006 | EP1673346A1 Quinazoline derivatives for the treatment of herpesviral infections |
| 06/28/2006 | EP1673343A2 Compounds and compositions as protein kinase inhibitors |
| 06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
| 06/28/2006 | EP1673341A1 Tetrahydropyridine derivatives |
| 06/28/2006 | EP1673339A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/28/2006 | EP1673338A1 Fatty acid compounds, preparation and uses thereof |
| 06/28/2006 | EP1673336A1 Cathepsin cysteine protease inhibitors |
| 06/28/2006 | EP1673133A1 Fluid medication delivery device |
| 06/28/2006 | EP1673107A2 Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker |
| 06/28/2006 | EP1673098A1 Methods and means for modulating lipid metabolism |
| 06/28/2006 | EP1673096A1 Use of a vitamin d3 analogue for the treatment of benign prostatic hyperplasia |
| 06/28/2006 | EP1673095A1 Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin d compounds |
| 06/28/2006 | EP1673094A1 Extended triphasic contraceptive regimens |
| 06/28/2006 | EP1673093A1 Use of steroidal quinols for estrogen replacement therapy |
| 06/28/2006 | EP1673092A1 Heterocycle-substituted pteridine derivatives and their use in therapy |
| 06/28/2006 | EP1673091A2 Therapeutic treatment |
| 06/28/2006 | EP1673090A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 06/28/2006 | EP1673089A2 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 06/28/2006 | EP1673088A1 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo¬2,3-c|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes |
| 06/28/2006 | EP1673087A2 Alkoxy substituted imidazoquinolines |
| 06/28/2006 | EP1673086A1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
| 06/28/2006 | EP1673085A2 C-met modulators and methods of use |
| 06/28/2006 | EP1673084A1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms |
| 06/28/2006 | EP1673083A2 N-substituted azacycles |
| 06/28/2006 | EP1673082A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 06/28/2006 | EP1673080A2 Pharmaceutical combination preparation containing glycyrrhizine, zinc, and a compound comprising a thiol group or a group that is metabolized thereto |
| 06/28/2006 | EP1673079A1 Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid |
| 06/28/2006 | EP1673078A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/28/2006 | EP1673077A1 Pharmaceutical compositions comprising malonamide derivatives for decreasing sebum production |
| 06/28/2006 | EP1673076A1 Breast cancer treatment regimen |
| 06/28/2006 | EP1673075A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 06/28/2006 | EP1673074A2 Liquid preparation containing tobramycin |
| 06/28/2006 | EP1673071A1 Improved stability of progestogen formulations |
| 06/28/2006 | EP1673069A1 Method of administering cationic liposomes comprising an active drug |
| 06/28/2006 | EP1673065A1 Microemulsions of retinoids, and pharmaceutical compositions containing them |
| 06/28/2006 | EP1673064A1 Pharmaceutical composition comprising anticonvulsant with taste mask coating |
| 06/28/2006 | EP1673063A1 Transdermal pharmaceutical composition |
| 06/28/2006 | EP1673062A2 Antimicrobial compositions and methods |
| 06/28/2006 | EP1673059A2 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 06/28/2006 | EP1673058A1 Composition and method for promoting hair growth |
| 06/28/2006 | EP1673055A1 Vegetable substitute for lanolin |
| 06/28/2006 | EP1672988A1 Weight-loss supplement |
| 06/28/2006 | EP1672978A2 Cobalamin conjugates for anti-tumor therapy |
| 06/28/2006 | EP1601677B1 Spiro-substituted pyrrolopyrimidines |
| 06/28/2006 | EP1594488B1 Stabilized pharmaceutical compositions of safingol and methods of using the same |
| 06/28/2006 | EP1569900B1 Substituted 3-carbonyl-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/28/2006 | EP1569899B1 Substituted 3-alkyl- and 3-arylalkyl-1h-indol-1-yl-acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/28/2006 | EP1562920B1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 06/28/2006 | EP1558199A4 Therapeutic combination of carnitine and antioxidant polyphenols |
| 06/28/2006 | EP1554276B1 Non-nucleoside reverse transcriptase inhibitors |
| 06/28/2006 | EP1544201B1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 06/28/2006 | EP1507874A4 Compositions and processes for inhibiting gene expression using polynucleotides |
| 06/28/2006 | EP1492539B1 Statin therapy for enhancing cognitive maintenance |
| 06/28/2006 | EP1485057B9 Derivatives of azaspiro compounds for the treatment of pain |
| 06/28/2006 | EP1404327B1 Dermatological composition comprising nicotinic acid or an amide, and a sphingoid base |
| 06/28/2006 | EP1401812B1 4-piperazinylindole derivatives with 5-ht6 receptor affinity |
| 06/28/2006 | EP1395261B1 Pyridylpyrimidine derivatives as effective compounds against prion diseases |
| 06/28/2006 | EP1392330B1 Use of lps for treating intestinal inflammation processes |
| 06/28/2006 | EP1379258B1 Low salt forms of polyallylamine |
| 06/28/2006 | EP1377591B1 Tumour inhibiting gallium compounds |
| 06/28/2006 | EP1372694B1 Liposome targeting of matrix metalloproteinase inhibitors |
| 06/28/2006 | EP1372636B1 Metronomic dosing of taxanes for inhibiting tumor growth |
| 06/28/2006 | EP1355644B1 The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 06/28/2006 | EP1341758B1 Coniosetin and derivatives thereof, method for producing the same and use thereof |
| 06/28/2006 | EP1299088B1 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient |
| 06/28/2006 | EP1280500B1 Synergistic antiplaque/antigingivitis oral composition |
| 06/28/2006 | EP1272653B1 Methods for ansamitocin production |
| 06/28/2006 | EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 06/28/2006 | EP1268405B1 Treatment of tumors with rar alpha selective retinoid compounds in combination with other anti-tumor agents |
| 06/28/2006 | EP1267901B9 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |
| 06/28/2006 | EP1267861B1 Composition comprising paracetamol and niflumic acid |
| 06/28/2006 | EP1259243B1 Bupropion metabolites and methods of their synthesis and use |
| 06/28/2006 | EP1255536B1 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2006 | EP1242066B1 Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder |
| 06/28/2006 | EP1229894B8 Cosmetic compositions containing chick pea extract and retinoids |
| 06/28/2006 | EP1214452B1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 06/28/2006 | EP1208140B1 Rapidly decomposing chitosan-based pellets |
| 06/28/2006 | EP1173517A4 In situ forming hydrogels |
| 06/28/2006 | EP1159756B1 Compounds for the treatment of cancer |
| 06/28/2006 | EP1156789B9 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 06/28/2006 | EP1154767B9 Substituted stilbene compounds with vascular damaging activity |
| 06/28/2006 | EP1121372B1 Adenine derivatives |